CASI Pharmaceuticals Inc
CASI - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.09M
Close$
$3.55
2259.1% upside
Current Fair Value
2259.1% upsideUndervalued by 2259.1% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.09 Million |
|---|---|
| Enterprise Value | $39.83 Million |
| Earnings per Share | $-2.56 |
| Beta | 0.89 |
| Outstanding Shares | 16,049,320 |
Return
| Return on Equity | 75.45% |
|---|---|
| Return on Assets | -208.70% |
| Return on Invested Capital | 87.72% |
Valuation & Multiples
| P/E Ratio | -0.06 |
|---|---|
| PEG | 0.23 |
| Price to Sales | 0.15 |
| Price to Book Ratio | -0.04 |
| Enterprise Value to Revenue | 1.98 |
| Enterprise Value to EBIT | -1 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.02 |
| Debt to Equity | -0.7 |
Revenue Sources
No data
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 7.83% |
|---|---|
| Total Invested | $25▼ 100.00% |
| Investors Holding | 1▼ 16.00% |
About CASI Pharmaceuticals Inc
214 employees
CEO: Wei-Wu He
CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on...